A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Clinical trial NCT00793156 · UNKNOWN
Trial details
- NCT number
- NCT00793156
- Sponsor
- Acologix, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2010-12-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.